Holdings of JPMorgan Healthcare Leaders ETF
J.P. Morgan Exchange-Traded Fund Trust · 59 declared positions · as of Apr 30, 2026
Original filing · Net assets 11.1M $ · Ten largest lines: 47 % of the equity sleeve
Sector breakdown
- Health care 66.8 %
- Unattributed 33.2 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 75.9 %
- EUR 6.3 %
- GBP 5.2 %
- CHF 4.8 %
- DKK 3.3 %
- JPY 3.0 %
- ILS 1.4 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 75.5 %
- GB 5.2 %
- CH 4.8 %
- BE 4.4 %
- DK 3.4 %
- JP 3.0 %
- DE 2.0 %
- IL 1.4 %
- CA 0.3 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 43 | 8.3M $ | 75.45 % |
| GB | 2 | 575.2K $ | 5.23 % |
| CH | 3 | 533.3K $ | 4.84 % |
| BE | 2 | 480.6K $ | 4.37 % |
| DK | 3 | 379.4K $ | 3.45 % |
| JP | 2 | 329.7K $ | 2.99 % |
| DE | 2 | 217.1K $ | 1.97 % |
| IL | 1 | 157K $ | 1.43 % |
| CA | 1 | 30K $ | 0.27 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Eli Lilly & Co | 811 | 758K $ | 6.81 % |
| AbbVie Inc | 3,464 | 732K $ | 6.58 % |
| Johnson & Johnson | 3,001 | 689.8K $ | 6.20 % |
| UnitedHealth Group Inc | 1,751 | 648.7K $ | 5.83 % |
| AstraZeneca PLC | 2,677 | 507.9K $ | 4.57 % |
| Merck & Co Inc | 4,289 | 468.3K $ | 4.21 % |
| Bristol-Myers Squibb Co | 6,427 | 389.4K $ | 3.50 % |
| Thermo Fisher Scientific Inc | 740 | 354.4K $ | 3.19 % |
| Intuitive Surgical Inc | 719 | 329K $ | 2.96 % |
| CVS Health Corp | 3,618 | 301.3K $ | 2.71 % |
| Novo Nordisk A/S | 6,943 | 295.3K $ | 2.65 % |
| Roche Holding AG | 723 | 294.6K $ | 2.65 % |
| Argenx SE | 334 | 261.9K $ | 2.35 % |
| Hoya Corp | 1,400 | 261.4K $ | 2.35 % |
| Regeneron Pharmaceuticals, Inc. | 344 | 243.2K $ | 2.19 % |
| Boston Scientific Corp | 3,946 | 227.3K $ | 2.04 % |
| UCB SA | 803 | 218.6K $ | 1.97 % |
| Vertex Pharmaceuticals Inc | 510 | 218K $ | 1.96 % |
| Danaher Corp | 1,184 | 211.9K $ | 1.90 % |
| Edwards Lifesciences Corp | 2,435 | 203.3K $ | 1.83 % |
| McKesson Corp | 243 | 198.1K $ | 1.78 % |
| Stryker Corp | 562 | 177.1K $ | 1.59 % |
| Teva Pharmaceutical Industries Ltd | 4,466 | 157K $ | 1.41 % |
| Cardinal Health, Inc. | 796 | 153.5K $ | 1.38 % |
| Centene Corp | 2,739 | 147.1K $ | 1.32 % |
| Biogen Inc | 764 | 144.6K $ | 1.30 % |
| Zoetis Inc | 1,136 | 130.6K $ | 1.17 % |
| United Therapeutics Corp | 226 | 129.1K $ | 1.16 % |
| Lonza Group AG | 200 | 123K $ | 1.11 % |
| Novartis AG | 783 | 115.7K $ | 1.04 % |
| Fresenius SE & Co. KGaA | 2,383 | 115.4K $ | 1.04 % |
| IQVIA Holdings Inc | 726 | 115K $ | 1.03 % |
| Sartorius AG | 398 | 101.7K $ | 0.91 % |
| Spyre Therapeutics Inc | 1,327 | 98.8K $ | 0.89 % |
| Apogee Therapeutics Inc | 1,152 | 95.5K $ | 0.86 % |
| Ionis Pharmaceuticals Inc | 1,257 | 94K $ | 0.84 % |
| CG oncology Inc | 1,304 | 87K $ | 0.78 % |
| Ascendis Pharma A/S | 343 | 78.7K $ | 0.71 % |
| Align Technology Inc | 437 | 76.9K $ | 0.69 % |
| Immunome Inc | 3,351 | 76.9K $ | 0.69 % |
| Dyne Therapeutics Inc | 4,266 | 74.9K $ | 0.67 % |
| Dexcom Inc | 1,196 | 71.2K $ | 0.64 % |
| Neurocrine Biosciences Inc | 533 | 70.2K $ | 0.63 % |
| Genmab A/S | 265 | 70.2K $ | 0.63 % |
| Daiichi Sankyo Co Ltd | 4,200 | 68.2K $ | 0.61 % |
| Convatec Group PLC | 23,481 | 67.3K $ | 0.61 % |
| Cigna Group/The | 231 | 67.1K $ | 0.60 % |
| Medtronic PLC | 808 | 65.4K $ | 0.59 % |
| Alumis Inc | 2,446 | 60.4K $ | 0.54 % |
| Nuvalent Inc | 584 | 58.6K $ | 0.53 % |
| Bio-Techne Corp | 843 | 46.6K $ | 0.42 % |
| Sionna Therapeutics Inc | 1,201 | 46.5K $ | 0.42 % |
| Disc Medicine Inc | 636 | 41.9K $ | 0.38 % |
| Alnylam Pharmaceuticals Inc | 112 | 34.7K $ | 0.31 % |
| Viridian Therapeutics Inc | 2,323 | 31.3K $ | 0.28 % |
| Evommune Inc | 1,260 | 30K $ | 0.27 % |
| Xenon Pharmaceuticals Inc | 535 | 30K $ | 0.27 % |
| HCA Healthcare Inc | 68 | 29.5K $ | 0.27 % |
| Genmab A/S | 523 | 13.9K $ | 0.12 % |